Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...
Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.
Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ...
Teacher Retirement System of Texas lifted its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 18.7% during the 4th quarter, according to the company in its most recent filing ...
The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication between nerve & muscle ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results